Market Size of Cell Lysis Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 8.50 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Cell Lysis Market Analysis
The cell lysis market is expected to register a CAGR of 8.5% over the forecast period.
Severe respiratory consequences of the COVID-19 pandemic prompted an urgent need for novel therapies that increased the number of drug discoveries, thereby positively impacting the cell lysis market. Several research studies were conducted to understand the effect of cell lysis on coronavirus. For instance, during the peak of the COVID-19 pandemic, the Department of Biotechnology (DBT) in India undertook a project to sequence 1,000 SARS-CoV-2 genomes from samples to understand the evolving behavior of the virus. The samples were collected across India to study the emerging mutations in the virus and how they change the symptoms of the disease. The increase in research activities that used different processes increased the demand for cell lysis devices and reagents.
The market is expected to grow due to increased expenditure on research and development, increasing application in the pharmaceutical and biopharmaceutical industries, and a rising focus on personalized medicine. Personalized medicine is one of the latest developments of gene-related studies that provide custom-tailored treatments as per the specific needs of patients, which has massive significance in disease prevention, diagnosis, prognosis, and therapeutics. According to the GLOBOCAN, in 2020, there were around 19,292,789 new cancer cases worldwide and about 9,958,133 deaths due to cancer. With the increase in the prevalence of infectious diseases and cancers, the use of cell samples for research and development of drugs also increases, which is expected to support the growth of the cell lysis market.
The high adoption of cell lysis and disruption methods during downstream processing to manufacture bio-therapeutics and other recombinant products further boosts the overall market growth. Furthermore, rising investments by governments and private organizations in R&D related to biotechnological processes and academics are expected to drive the market significantly. However, regulatory compliance and issues in the mechanical process in applying at the microscale level are some factors that might hinder market growth.
Cell Lysis Industry Segmentation
As per the scope of the report, cell lysis is one of the major steps in biological research to remove biological materials and use them in various downstream applications to fulfill research goals. Cell lysis is used in many industries, from pharmaceuticals to food, cosmetics, and biotechnology. The cell lysis market is segmented by product (instruments and reagents), type of cells (mammalian cells, microbial cells, and plant cells), end user (biotechnology or biopharmaceutical companies, research laboratories and academic institutes, and other end users), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report also covers estimated market sizes and trends for 17 different countries across major regions. The report offers all values in USD million for the above segments.
| By Type of Product | |||||
| |||||
| Reagents |
| By Type of Cells | |
| Mammalian Cells | |
| Microbial Cells | |
| Plant Cells |
| By End User | |
| Biotechnology or Biopharmaceutical Companies | |
| Research Laboratories and Academic Institutes | |
| Other End Users |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Cell Lysis Market Size Summary
The cell lysis market is poised for significant growth, driven by increased research and development activities and the rising application of cell lysis techniques in the pharmaceutical and biopharmaceutical sectors. The demand for cell lysis devices and reagents has surged, particularly due to the urgent need for novel therapies during the COVID-19 pandemic, which spurred numerous drug discoveries and research studies. The market is further bolstered by the growing focus on personalized medicine, which tailors treatments to individual patient needs, and the increasing prevalence of infectious diseases and cancers. These factors have led to a heightened use of cell samples in drug research and development, supporting the market's expansion. The adoption of cell lysis methods in the production of biotherapeutics and recombinant products, along with substantial investments in biotechnological research, are also contributing to the market's growth trajectory.
North America leads the cell lysis market, fueled by substantial research and development expenditures and a high incidence of chronic diseases. The region's response to COVID-19, including increased lab testing and vaccine development, has further driven demand for cell lysis systems and reagents. The market is characterized by moderate competition, with both local and international companies like Thermo Fisher Scientific, Merck KGaA, and F. Hoffmann-La Roche Ltd playing significant roles. These companies are focusing on novel product developments and strategic collaborations to strengthen their market positions. The continuous advancement of healthcare infrastructure and the growing patient population in the United States present further opportunities for market expansion. Additionally, recent technological advancements, such as the use of microfluidic devices in cell lysis, are expected to enhance market growth.
Cell Lysis Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increasing Expenditure in Research and Development
-
1.2.2 Increasing Application in the Pharmaceutical and Biopharmaceutical Industries
-
1.2.3 Rising Focus on Personalized Medicine
-
-
1.3 Market Restraints
-
1.3.1 Regulatory Compliance
-
1.3.2 Issues in Mechanical Process to Apply at the Microscale Level
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size - Value in USD million)
-
2.1 By Type of Product
-
2.1.1 Instruments
-
2.1.1.1 Homogeniser
-
2.1.1.2 Centrifugation
-
2.1.1.3 Other Types of Products
-
-
2.1.2 Reagents
-
-
2.2 By Type of Cells
-
2.2.1 Mammalian Cells
-
2.2.2 Microbial Cells
-
2.2.3 Plant Cells
-
-
2.3 By End User
-
2.3.1 Biotechnology or Biopharmaceutical Companies
-
2.3.2 Research Laboratories and Academic Institutes
-
2.3.3 Other End Users
-
-
2.4 Geography
-
2.4.1 North America
-
2.4.1.1 United States
-
2.4.1.2 Canada
-
2.4.1.3 Mexico
-
-
2.4.2 Europe
-
2.4.2.1 Germany
-
2.4.2.2 United Kingdom
-
2.4.2.3 France
-
2.4.2.4 Italy
-
2.4.2.5 Spain
-
2.4.2.6 Rest of Europe
-
-
2.4.3 Asia-Pacific
-
2.4.3.1 China
-
2.4.3.2 Japan
-
2.4.3.3 India
-
2.4.3.4 Australia
-
2.4.3.5 South Korea
-
2.4.3.6 Rest of Asia-Pacific
-
-
2.4.4 Middle East and Africa
-
2.4.4.1 GCC
-
2.4.4.2 South Africa
-
2.4.4.3 Rest of Middle East and Africa
-
-
2.4.5 South America
-
2.4.5.1 Brazil
-
2.4.5.2 Argentina
-
2.4.5.3 Rest of South America
-
-
-
Cell Lysis Market Size FAQs
What is the current Cell Lysis Market size?
The Cell Lysis Market is projected to register a CAGR of 8.5% during the forecast period (2024-2029)
Who are the key players in Cell Lysis Market?
Thermo Fisher Scientific, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Merck KGaA and Danaher Corporation are the major companies operating in the Cell Lysis Market.
